Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Mar 26;20(10):2399–2401.e4. doi: 10.1016/j.cgh.2021.03.028

Figure 1. Reasons for dose-intensification (A) and outcomes after dose-intensification (B).

Figure 1.

Clinical follow-up data after dose-intensification was available for 40/46 patients.

There were no significant differences between q4w and q6w outcomes using p<0.05 by Fisher’s exact test

*Post-intensification endoscopic data was available for n=9 for q4w, n=7 for q6w.